Michael Festing

Michael Festing is a British research scientist best known for his work on animal testing. He is one of 19 members of the UK Animal Procedures Committee, which advises the Home Secretary on matters related to animal experimentation, one of five trustees of the Fund for the Replacement of Animals in Medical Experiments (FRAME), which is financed by the pharmaceutical and animal-testing industries, [1] and a council member of the Institute of Laboratory Animals Research USA. [2]

He is the author of over 200 scientific papers on laboratory-animal genetics and related issues. He has a particular interest in improving the design of animal experiments, particularly in the area of toxicology testing, and was the winner in 1996 of the GlaxoSmithKline Laboratory Animal Welfare Prize 1996, for his work while at the University of Leicester for "improved experimental design leading to reductions in the use of laboratory animals." [3]

Festing has been criticized by the animal-rights movement for his investment in companies that engage in animal testing, which according to the Animal Procedures Committee register of members' interests [4] include AstraZeneca, GlaxoSmithKline, Alizyme, Akambis, Cambridge Antibody, Shire Pharmaceuticals, and Celltech. [5]

Life and education

Festing is a chartered statistician, has a Ph.D in quantitative genetics from Iowa State University, and a D.Sc. from the University of London.

He is the father of Simon Festing, the executive director of the Research Defence Society, which focuses on supplying information about, and defending, the use of animals in medical experiments in the UK.

References

• Brief biography of Michael Festing, PharmaDiscovery, retrieved February 22, 2006
• Corporate members of FRAME, Fund for the Replacement of Animals in Medical Experiments, retrieved February 22, 2006
• Current APC Members and Register of Interests, Animal Procedures Committee, retrieved February 22, 2006
• "RDS, Michael Festing, and Simon Festing: Who's Who", Americans for Medical Advancement, retrieved February 22, 2006
• "GlaxoSmithKline laboratory animal welfare prize", Research Defence Society